📰 Robert Iannone News
Robert Iannone News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Robert Iannone. Real-time updates on events, politics, business and more.
February 7, 2024
Redx is eligible to receive up to $870m in development, regulatory and commercial milestone payments from Jazz.
February 7, 2024
Lisa Anson says partnerships remain key pillar of RedX corporate strategy
February 7, 2024
(RTTNews) - Jazz Pharmaceuticals plc (JAZZ) Wednesday said it has signed a definitive agreement to acquire Redx Pharma plcs (REDX.L) proprietary ...
November 9, 2023
Operator: Good afternoon. My name is Krista, and Ill be your conference operator today. At this time, I would like to welcome everyone to the Jazz Pharmaceuticals Third Quarter 2023 Earnings Call.
September 22, 2023
The European Commission has granted marketing authorization for Rylaze for use as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia and lymphoblastic lymphoma in adult and pediatric patients 1 month and older who developed hypersensitivity or silent inactivation to E. coli–derived asparaginase.
September 21, 2023
DUBLIN, Sept. 21, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc today announced that the European Commission has granted marketing authorization for Enrylaze® for use as a component of a...
August 7, 2023
Autolus Therapeutics plc (NASDAQ:AUTL) Q2 2023 Earnings Call Transcript August 6, 2023 Operator: Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics Second Quarter 2023 Financial Results Conference. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that […]
August 7, 2023
Operator: Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics Second Quarter 2023 Financial Results Conference. At this time, all participants are in a listen-only mode.
July 21, 2023
The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended the approval of JZP458 for use in combination with multi-agent chemotherapy for the treatment of adult and pediatric patients 1 month and older with acute lymphoblastic leukemia and lymphoblastic lymphoma who developed hypersensitivity or silent inactivation to Escherichia coli–derived asparaginase.
June 23, 2023
Daniel Hersog discusses new album.